Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 2
1(25.0%)
4Total
N/A(3)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT04416841Not ApplicableCompleted

Tai Chi Chuan as Rehabilitation Program for Mild Cognitive Impairment in Type 2 Diabetes Mellitus Patients

Role: collaborator

NCT01946919Completed

Post-Marketing Surveillance of the Cinepazide Maleate Injection: a Real World Study

Role: collaborator

NCT01573858Not ApplicableCompleted

Acupuncture and Clomiphene Citrate on Live Birth in Anovulatory Women With Polycystic Ovary Syndrome

Role: collaborator

NCT04408261Phase 2Unknown

BuqitongluO Granule for Qi Deficiency and Blood Stasis Syndrome

Role: collaborator

NCT04531683Not ApplicableUnknown

Effect of Electroacupuncture on Mixed Urinary Incontinence Among Women

Role: collaborator

All 5 trials loaded